JP Patent

JP6987501B2 — 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態

Assigned to ライゼン・ファーマシューティカルズ・エスアー · Expires 2022-01-05 · 4y expired

What this patent protects

Patent listed against umbralisib-tosylate.

Drugs covered by this patent

Patent Metadata

Patent number
JP6987501B2
Jurisdiction
JP
Classification
—
Expires
2022-01-05
Drug substance claim
No
Drug product claim
No
Assignee
ライゼン・ファーマシューティカルズ・エスアー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.